Anti-EGFR-Anti-RNF43 AbTAC

BPS Bioscience

Anti-EGFR-Anti-RNF43 AbTAC

23

Research Use Only

Monoclonal

≥85%

EGFR

epidermal growth factor receptor

ERBB, ERBB1, ERRP, HER1, NISBD2, NNCIS, PIG61, mENA, epidermal growth factor receptor, EGFR vIII, avian erythroblastic leukemia viral (v-erb-b) oncogene homolog, cell growth inhibiting protein 40, cell proliferation-inducing protein 61, epidermal growth factor receptor tyrosine kinase domain, erb-b2 receptor tyrosine kinase 1, proto-oncogene c-ErbB-1, receptor tyrosine-protein kinase erbB-1

Human

IgG1

Epidermal growth factor receptor

This anti-EGFR-anti-RNF43 AbTAC (Antibody-based Targeted Protein Degradation) is a purified, recombinant monoclonal antibody that recognizes human EGFR (epidermal growth factor receptor) and human RNF43 (ring finger protein 43). This antibody has been functionally tested in a flow cytometry assay for its ability to induce targeted degradation of EGFR.

-80°C

41116161

Human